BRISTOL-MYERS SQUIBB CO (1BMY.MI) Stock Fundamental Analysis

BIT:1BMY • US1101221083

51.43 EUR
+0.41 (+0.8%)
Last: Feb 16, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Overall 1BMY gets a fundamental rating of 5 out of 10. We evaluated 1BMY against 49 industry peers in the Pharmaceuticals industry. While 1BMY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1BMY has a bad growth rate and is valued cheaply. 1BMY also has an excellent dividend rating. With these ratings, 1BMY could be worth investigating further for value and dividend investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • 1BMY had positive earnings in the past year.
  • 1BMY had a positive operating cash flow in the past year.
  • 1BMY had positive earnings in 4 of the past 5 years.
  • In the past 5 years 1BMY always reported a positive cash flow from operatings.
1BMY.MI Yearly Net Income VS EBIT VS OCF VS FCF1BMY.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

1.2 Ratios

  • The Return On Assets of 1BMY (7.83%) is better than 61.54% of its industry peers.
  • 1BMY has a better Return On Equity (38.19%) than 90.38% of its industry peers.
  • 1BMY has a better Return On Invested Capital (19.52%) than 80.77% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1BMY is in line with the industry average of 13.98%.
  • The last Return On Invested Capital (19.52%) for 1BMY is above the 3 year average (14.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROIC 19.52%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
1BMY.MI Yearly ROA, ROE, ROIC1BMY.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • The Profit Margin of 1BMY (14.64%) is comparable to the rest of the industry.
  • 1BMY's Profit Margin has improved in the last couple of years.
  • The Operating Margin of 1BMY (35.82%) is better than 88.46% of its industry peers.
  • In the last couple of years the Operating Margin of 1BMY has grown nicely.
  • 1BMY's Gross Margin of 72.63% is in line compared to the rest of the industry. 1BMY outperforms 59.62% of its industry peers.
  • 1BMY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
1BMY.MI Yearly Profit, Operating, Gross Margins1BMY.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1BMY is creating value.
  • 1BMY has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, 1BMY has less shares outstanding
  • Compared to 1 year ago, 1BMY has an improved debt to assets ratio.
1BMY.MI Yearly Shares Outstanding1BMY.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
1BMY.MI Yearly Total Debt VS Total Assets1BMY.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • 1BMY has an Altman-Z score of 2.55. This is not the best score and indicates that 1BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 1BMY (2.55) is comparable to the rest of the industry.
  • The Debt to FCF ratio of 1BMY is 3.51, which is a good value as it means it would take 1BMY, 3.51 years of fcf income to pay off all of its debts.
  • 1BMY's Debt to FCF ratio of 3.51 is fine compared to the rest of the industry. 1BMY outperforms 71.15% of its industry peers.
  • A Debt/Equity ratio of 2.33 is on the high side and indicates that 1BMY has dependencies on debt financing.
  • 1BMY has a Debt to Equity ratio of 2.33. This is in the lower half of the industry: 1BMY underperforms 78.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Altman-Z 2.55
ROIC/WACC2.27
WACC8.58%
1BMY.MI Yearly LT Debt VS Equity VS FCF1BMY.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • 1BMY has a Current Ratio of 1.26. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
  • 1BMY has a Current ratio of 1.26. This is comparable to the rest of the industry: 1BMY outperforms 40.38% of its industry peers.
  • 1BMY has a Quick Ratio of 1.14. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
  • 1BMY's Quick ratio of 1.14 is fine compared to the rest of the industry. 1BMY outperforms 67.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.14
1BMY.MI Yearly Current Assets VS Current Liabilites1BMY.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • 1BMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 439.47%, which is quite impressive.
  • Measured over the past years, 1BMY shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.92% on average per year.
  • 1BMY shows a decrease in Revenue. In the last year, the revenue decreased by -0.22%.
  • Measured over the past years, 1BMY shows a small growth in Revenue. The Revenue has been growing by 2.54% on average per year.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%

3.2 Future

  • Based on estimates for the next years, 1BMY will show a decrease in Earnings Per Share. The EPS will decrease by -4.54% on average per year.
  • Based on estimates for the next years, 1BMY will show a decrease in Revenue. The Revenue will decrease by -5.62% on average per year.
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1BMY.MI Yearly Revenue VS Estimates1BMY.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
1BMY.MI Yearly EPS VS Estimates1BMY.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.87, which indicates a very decent valuation of 1BMY.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 90.38% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of 1BMY to the average of the S&P500 Index (27.07), we can say 1BMY is valued rather cheaply.
  • The Price/Forward Earnings ratio is 9.98, which indicates a very decent valuation of 1BMY.
  • Based on the Price/Forward Earnings ratio, 1BMY is valued cheaper than 84.62% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.05, 1BMY is valued rather cheaply.
Industry RankSector Rank
PE 9.87
Fwd PE 9.98
1BMY.MI Price Earnings VS Forward Price Earnings1BMY.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 92.31% of the companies in the same industry are more expensive than 1BMY, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, 1BMY is valued cheaper than 96.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.62
EV/EBITDA 7.39
1BMY.MI Per share data1BMY.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • The decent profitability rating of 1BMY may justify a higher PE ratio.
  • 1BMY's earnings are expected to decrease with -3.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • 1BMY has a Yearly Dividend Yield of 4.12%, which is a nice return.
  • 1BMY's Dividend Yield is rather good when compared to the industry average which is at 1.84. 1BMY pays more dividend than 86.54% of the companies in the same industry.
  • 1BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.12%

5.2 History

  • The dividend of 1BMY is nicely growing with an annual growth rate of 6.51%!
Dividend Growth(5Y)6.51%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 71.52% of the earnings are spent on dividend by 1BMY. This is not a sustainable payout ratio.
  • 1BMY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
1BMY.MI Yearly Income VS Free CF VS Dividend1BMY.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B
1BMY.MI Dividend Payout.1BMY.MI Dividend Payout, showing the Payout Ratio.1BMY.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BRISTOL-MYERS SQUIBB CO

BIT:1BMY (2/16/2026, 7:00:00 PM)

51.43

+0.41 (+0.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners81.87%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap104.70B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.59
Price Target52.72 (2.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.12%
Yearly Dividend2.13
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)7.63%
PT rev (3m)11.64%
EPS NQ rev (1m)1.09%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)0.24%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)3.32%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)6.84%
Revenue NY rev (3m)7.45%
Valuation
Industry RankSector Rank
PE 9.87
Fwd PE 9.98
P/S 2.56
P/FCF 9.62
P/OCF 8.73
P/B 6.69
P/tB N/A
EV/EBITDA 7.39
EPS(TTM)5.21
EY10.13%
EPS(NY)5.15
Fwd EY10.02%
FCF(TTM)5.34
FCFY10.39%
OCF(TTM)5.89
OCFY11.45%
SpS20.05
BVpS7.69
TBVpS-9.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.02
Profitability
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROCE 25.91%
ROIC 19.52%
ROICexc 23.22%
ROICexgc 84.94%
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
FCFM 26.65%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Debt/EBITDA 2.03
Cap/Depr 32.69%
Cap/Sales 2.72%
Interest Coverage 8.22
Cash Conversion 66.54%
Profit Quality 182.1%
Current Ratio 1.26
Quick Ratio 1.14
Altman-Z 2.55
F-Score7
WACC8.58%
ROIC/WACC2.27
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.75%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.78%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%

BRISTOL-MYERS SQUIBB CO / 1BMY.MI FAQ

Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a fundamental rating of 5 / 10 to 1BMY.MI.


Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a valuation rating of 7 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.


Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?

BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 7 / 10.


Can you provide the financial health for 1BMY stock?

The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.


Is the dividend of BRISTOL-MYERS SQUIBB CO sustainable?

The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 7 / 10 and the dividend payout ratio is 71.52%.